Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;97:305-313
Published online before print July 21, 2005, doi: 10.1161/01.RES.0000177893.24574.13
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
97/4/305    most recent
01.RES.0000177893.24574.13v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamimura, M.
Right arrow Articles by Bea, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamimura, M.
Right arrow Articles by Bea, F.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Acute coronary syndromes
(Circulation Research. 2005;97:305.)
© 2005 American Heart Association, Inc.


Molecular Medicine

Interleukin-10 Suppresses Tissue Factor Expression in Lipopolysaccharide-Stimulated Macrophages via Inhibition of Egr-1 and a Serum Response Element/MEK-ERK1/2 Pathway

Motohiro Kamimura, Christiane Viedt, Alexander Dalpke, Michael E. Rosenfeld, Nigel Mackman, David M. Cohen, Erwin Blessing, Michael Preusch, Christian M. Weber, Jörg Kreuzer, Hugo A. Katus, Florian Bea

From the Departments of Internal Medicine III (M.K., C.V., E.B., M.P., C.M.W., J.K., H.A.K., F.B.) and Hygiene and Medical Microbiology (A.D.), University of Heidelberg, Germany; the Department of Pathobiology and Interdisciplinary Graduate Program in Nutritional Sciences (M.E.R.), University of Washington, Seattle; The Scripps Research Institute (N.M.), La Jolla, Calif; and the Department of Nephrology and Hypertension (D.M.C.), Oregon Health and Science University and the Portland V.A. Medical Center, Portland, Ore.

Correspondence to Florian Bea, MD, Innere Medizin III, Universität Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. E-mail florian.bea{at}med.uni-heidelberg.de

Atherosclerosis is considered to be an inflammatory disease. Tissue factor (TF), a prothrombotic molecule expressed by various cell types within atherosclerotic plaques, is thought to play an essential role in thrombus formation after atherosclerotic plaque rupture. Recent studies suggest that the antiinflammatory cytokine interleukin-10 (IL-10) has many antiatherosclerotic properties. Therefore, the effects of IL-10 on TF expression in response to inflammation were investigated. Mouse macrophages were stimulated with lipopolysaccharide (LPS) in the presence or absence of IL-10. Pretreatment with IL-10 resulted in a 50% decrease in TF mRNA expression and TF promoter activity. Binding of early growth response gene-1 (Egr-1) to the consensus DNA sequence, a key transcriptional activator of TF expression in response to inflammation, and the expression of Egr-1 mRNA were also inhibited by IL-10. This inhibition was independent of the induction of suppressor of cytokine signaling protein-3 by IL-10. Macrophages that had been transfected with luciferase reporter constructs containing the murine Egr-1 5'-flanking sequence exhibited reduced reporter gene activity in response to LPS stimulation with IL-10 pretreatment. Studies with deletion constructs of the Egr-1 promoter identified the proximal serum response element SRE3 as a potential regulatory site for the IL-10 mediated suppression of Egr-1 expression. Furthermore, activation of the upstream signal-transduction elements, such as mitogen-activated protein kinase kinase (MEK) 1/2, extracellular signal-regulated kinase 1/2, and Elk-1 were also inhibited by IL-10 pretreatment. Taken together, these results demonstrate a pathway for the IL-10 mediated inhibition of TF expression during inflammation and may explain the antiatherosclerotic effects of IL-10.


Key Words: atherosclerosis • tissue factor • interleukin • early growth response gene • macrophages




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
F. Zare, M. Magnusson, L. N. Mollers, T. Jin, A. Tarkowski, and M. Bokarewa
Single-stranded polyinosinic acid oligonucleotides trigger leukocyte production of proteins belonging to fibrinolytic and coagulation cascades
J. Leukoc. Biol., September 1, 2008; 84(3): 741 - 747.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Cornish, B. J. Hurtgen, K. McInnerney, N. L. Burritt, R. M. Taylor, J. N. Jarvis, S. Y. Wang, and J. B. Burritt
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase-Independent Resistance to Aspergillus fumigatus in Alveolar Macrophages
J. Immunol., May 15, 2008; 180(10): 6854 - 6867.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Minami, K. Shimizu, Y. Okamoto, E. Folco, M.-L. Ilasaca, M. W. Feinberg, M. Aikawa, and P. Libby
Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-{kappa}B1 and Attenuates Macrophage Activation
J. Biol. Chem., April 11, 2008; 283(15): 9692 - 9703.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Klingenberg, J.-R. Nofer, M. Rudling, F. Bea, E. Blessing, M. Preusch, H. J. Grone, H. A. Katus, G. K. Hansson, and T. J. Dengler
Sphingosine-1-Phosphate Analogue FTY720 Causes Lymphocyte Redistribution and Hypercholesterolemia in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. Rajasingh, E. Bord, C. Luedemann, J. Asai, H. Hamada, T. Thorne, G. Qin, D. Goukassian, Y. Zhu, D. W. Losordo, et al.
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression
FASEB J, October 1, 2006; 20(12): 2112 - 2114.
[Abstract] [Full Text] [PDF]